WASHINGTON, D.C. – Today, U.S. Senators Rand Paul (R-KY) and Maggie Hassan (D-NH), both members of the Health, Education, Labor, and Pensions Committee, reintroduced bipartisan legislation to streamline the approval process for generic medications, which are often significantly cheaper than their brand-name counterparts. The bipartisan Increasing Transparency in Generic Drug Applications Act would help get generic medications onto the market faster and lower prescription drug prices for consumers.

WASHINGTON, D.C. – Today, U.S. Senators Rand Paul (R-KY) and Cory Booker (D-NJ) introduced an updated version of the Breakthrough Therapies Act. This legislation will remove regulatory hurdles that inhibit research and compassionate use access to potentially lifesaving treatments that are heavily restricted by Schedule I of the Controlled Substances Act.